Elsevier

Hepatology

Volume 21, Issue 1, January 1995, Pages 35-40
Hepatology

Other clinical study
Plasma levels of substance p in liver cirrhosis: Relationship to the activation of vasopressor systems and urinary sodium excretion

https://doi.org/10.1016/0270-9139(95)90405-0Get rights and content

Abstract

The mediators of the hyperdynamic circulation of liver cirrhosis are not well characterized. Substance P is a potent vasodilatory peptide produced by the enteric nervous system and partly cleared by the liver. In this work we have investigated the plasma levels of substance P and their relationship to the hemodynamic, neurohormonal, and renal function changes occurring in patients with cirrhosis. Seven healthy subjects (control group), 7 cirrhotic patients without ascites (group I), and 24 cirrhotic patients with ascites (group II) were studied. Cardiac output (CO), femoral blood flow (FBF), blood volume (BV), femoral arteriovenous difference of oxygen content (Ca-v O2), plasma renin activity (PRA), plasma aldosterone concentration (PAC), and plasma norepinephrine (NE) were determined. Five patients underwent trans-jugular intrahepatic porto-systemic stent shunt (TIPSS) because of refractory ascites. Immunoreactive substance P (irSP) was measured by radioimmunoassay after plasma extraction. irSP was higher in ascitic patients than in healthy controls (P < .01) and directly correlated with PRA, PAC, plasma NE, and Pugh's score and was inversely correlated with urinary sodium excretion, glomerular filtration rate, and Ca-v O2. No differences were observed between portal and peripheral vein irSP concentration. TIPSS placement induced a decrease in portal pressure and an increase in CO but circulating irSP remained unchanged. Our data show that circulating irSP is increased in decompensated cirrhotic patients and may be involved in the pathogenesis of the hemodynamic changes of cirrhosis. Alleviation of portal hypertension did not result in decreased plasma levels of this vasodilatory substance.

References (30)

  • D Regoli et al.

    New selective agonist for neurokinin receptors: pharmacological tools for receptor characterization

    Trends Pharmacol Sci

    (1988)
  • Withrington-PG

    The actions of two sensory neuropeptides, substance P and calcitonin gene-related peptide, on the canine hepatic arterial and portal vascular beds

    Br J Pharmacol

    (1992)
  • P Melchiorri et al.

    Comparative curculatory effects of substance P, eledoisin and physalamin in the dog

  • Sakai-H Inoue-N et al.

    Distribution and possible origins of substance P-containing nerve fibers in the rat liver

    Anat Anz

    (1992)
  • LL Iversen

    Substance P

    Br Med Bull

    (1982)
  • Cited by (52)

    • Pretransplantation Evaluation: Renal

      2015, Transplantation of the Liver: Third Edition
    • Pathophysiological basis of albumin use in cirrhosis

      2011, Annals of Hepatology
      Citation Excerpt :

      This is manifested primarily by the development of renal failure. The administration of diuretics, therapeutic paracentesis without albumin12,13 or severe bacterial infections15,33 are associated with renal failure in approximately 15-30% of these patients. Under physiological conditions the regulation of blood pressure and effective arterial blood volume is carried out mainly in the splanchnic and renal vascular compartments.

    • Relationship Between Activation of the Sympathetic Nervous System and Renal Blood Flow Autoregulation in Cirrhosis

      2008, Gastroenterology
      Citation Excerpt :

      The reduction in noradrenaline levels was statistically significant, but this was not normalized and was significantly higher than normal and similar to that in patients with diuretic-responsive ascites. These results of the reduction in noradrenaline levels are in keeping with previous studies, which have also shown a similar significant reduction in the levels of systemic noradrenaline at different time points after insertion of a TIPS.26,36–39 This would suggest that a therapeutic TIPS insertion alters the renal sympathetic drive, moving the patients toward a higher renal blood flow by causing an upward and leftward shift with a more pronounced plateau of the renal blood flow/renal perfusion pressure relationship curve.

    View all citing articles on Scopus

    Supported by grants from Fondo de Investigaciones Sanitarias and Fundación Ramón Areces. Dr. Fernández-Rodriguez is recipient of grant no. 92/1071 from the Fondo de Investigaciones Sanitarias, Spain.

    View full text